Prestigious Prize Honors Groundbreaking Body's Defenses Discoveries

The prestigious award in medical science has been awarded for transformative discoveries that clarify how the immune system targets dangerous pathogens while sparing the healthy tissues.

Three esteemed scientists—Japan's Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

Their research uncovered unique "sentinels" within the immune system that remove rogue defense cells that could harming the organism.

The findings are now paving the way for innovative treatments for autoimmune diseases and cancer.

The winners will share a monetary award worth 11m Swedish kronor.

Decisive Findings

"The work has been essential for comprehending how the body's defenses functions and why we do not all suffer from serious autoimmune diseases," stated the head of the Nobel Committee.

This team's research address a core question: How does the defense system protect us from countless infections while keeping our own tissues intact?

Our body's protection system employs immune cells that search for signs of disease, even viruses and germs it has never encountered.

These cells employ sensors—called recognition units—that are generated randomly in a vast number of variations.

This gives the immune system the ability to combat a wide array of invaders, but the randomness of the process unavoidably creates white blood cells that can target the host.

Protectors of the Body

Researchers earlier understood that some of these harmful defense cells were destroyed in the thymus—where white blood cells develop.

This year's Nobel Prize honors the discovery of T-reg cells—known as the body's "peacekeepers"—which travel through the body to neutralize other immune cells that assault the healthy cells.

It is known that this process fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.

The prize committee added, "The findings have laid the foundation for a novel area of investigation and spurred the creation of innovative therapies, for instance for tumors and autoimmune diseases."

Regarding cancer, regulatory T-cells prevent the body from fighting the tumor, so research are aimed at lowering their quantity.

For self-attack disorders, experiments are testing boosting regulatory T-cells so the organism is no longer under attack. A similar method could also be useful in minimizing the risks of transplanted organ failure.

Innovative Studies

Prof Shimon Sakaguchi, of Osaka University, performed tests on mice that had their immune gland removed, leading to autoimmune disease.

The researcher showed that introducing immune cells from other mice could prevent the illness—implying there was a system for preventing defenders from attacking the body.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in a California city, were investigating an inherited autoimmune disease in rodents and people that resulted in the discovery of a gene vital for the way regulatory T-cells operate.

"The groundbreaking research has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly targeting the healthy cells," commented a leading physiology specialist.

"The work is a striking example of how basic biological study can have broad implications for human health."